Elevated plasma levels of LCN2 have also been detected in ischemic and hemorrhagic stroke patients and are associated with worsened clinical outcome [10] and LCN2 is currently employed as a biomarker of brain injury [11, 12]. Here, LCN2 is linked to hemorrhagic stroke.